Continuous Passive Motion Devices Market Size, Share, Growth, and Industry Analysis, By Type (Hip Joint,Knee Joint,Shoulder Joint,Ankle Joint,Temporal Mandibular Joint), By Application (Children Below Age 13,Adult,Geriatric), Regional Insights and Forecast to 2035

Continuous Passive Motion Devices Market Overview

The global Continuous Passive Motion Devices Market is forecast to expand from USD 665.3 million in 2026 to USD 689.98 million in 2027, and is expected to reach USD 923.59 million by 2035, growing at a CAGR of 3.71% over the forecast period.

The global Continuous Passive Motion Devices Market shows distinct design distribution: portable devices comprise approximately 57% of installations, while fixed models account for the remainder. Demographic usage splits into adults at 57%, geriatrics at 30%, and children below 13 at 10%. North America leads worldwide with 47.3% market share, followed by Europe at 24.7%, Asia-Pacific at 17.6%, and Middle East & Africa around 5%. Knee joint CPM devices make up about 41.3% of installations, the largest application segment. These figures inform the Continuous Passive Motion Devices Market Size and highlight the critical Continuous Passive Motion Devices Market Insights.

Within the USA, the Continuous Passive Motion Devices Market demonstrates dominance, contributing the majority share within North America’s 47.3%, and comprising over 34.4% of global share as North America itself accounts for 34.4%. The U.S. leads in joint reconstruction rates, notably knee and hip arthroplasty, with over 427,000 annual joint replacements reported in North America between 2012 and 2015, approaching 4 million by 2030. Portable units constitute 57% of installations, with hospitals holding a 44.2% usage share, signaling prominent hospital-led adoption in the U.S. reflecting Continuous Passive Motion Devices Market Analysis for the U.S.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: Portable devices constitute 57% of the market, driving adoption across home care and hospitals by meeting patient mobility needs aligned with Continuous Passive Motion Devices Market Driver intelligence.
• Major Market Restraint: High device and treatment costs constrain about high-cost barrier percentage, limiting adoption – cost cited as primary restraint ( unspecified constraining percent).
• Emerging Trends: Smart CPM innovations comprise over 8% of new product launches in Asia-Pacific, indicating rising digital integration across Continuous Passive Motion Devices Market Trends.
• Regional Leadership: North America captures 47.3% of global market share, standing as the regional leader in Continuous Passive Motion Devices Market Regional Leadership.
• Competitive Landscape: Adults segment holds 57%, geriatrics 30%, children 10%, shaping the demographic competitive dominance in Continuous Passive Motion Devices Market Competitive Landscape.
• Market Segmentation: Knee joint devices represent about 41.3% of segment installations, defining the largest segment in Continuous Passive Motion Devices Market Segmentation.
• Recent Development: Smart and portable CPM devices introduced in late 2023 accounted for over 8% of launch activity, marking technological progression in Continuous Passive Motion Devices Market Latest Development.

Continuous Passive Motion Devices Market Latest Trends

The Continuous Passive Motion Devices Market Latest Trends reveal a shift toward digital integration, accounting for over 8% of new launches in Asia-Pacific during 2023. These smart CPM devices incorporate sensors for real-time monitoring and mobile or cloud features, enhancing therapy personalization. Portable devices dominate installations at 57%, enabling home-based rehabilitation and continued usage beyond hospital discharge; this aligns with demand for convenient, cost-effective solutions. Knee joint devices remain the leading application, capturing around 41.3% of usage, followed by hip and shoulder segments. Hospitals hold a 44.2% end-user share, underscoring institutional reliance, although home-care is gaining ground. North America dominates the market with 47.3% share, boosted by joint surgery prevalence and regulatory approvals. Europe follows at 24.7%, with portable CPM units forming over 50% of that region’s units. In Asia-Pacific, adults constitute 57% of users and geriatrics 30%, while children below 13 represent 10%, illustrating cross-demographic appeal. Smart portable CPM models launched in late 2023 led new product entries, roughly 8% of all launches in the region. These trends underscore the market’s evolution toward technology-enabled, user-friendly, and home-application-ready devices under the banner of Continuous Passive Motion Devices Market Trends.

Continuous Passive Motion Devices Market Dynamics

DRIVER

"Rising demand for postoperative rehabilitation"

The Continuous Passive Motion Devices Market Dynamics emphasize the rising demand for postoperative rehabilitation as a central driver. Knee and hip arthroplasty procedures account for over 427,000 annual joint replacements in North America between 2012 and 2015, with projections trending toward 4 million by 2030. Adults form 57% of device users, reflecting broad applicability across recovery stages. Hospitals account for 44.2% of installations, showing institutional reliance on CPM therapy. Portable units, representing 57% of devices, meet the growing need for flexible rehabilitation tools during and after hospital stays. The dominance of knee joint devices about 41.3% reflects focused demand in orthopedic recovery. Together, these numbers illustrate how procedural volumes and demographic needs are propelling market expansion in Continuous Passive Motion Devices Market Growth.

RESTRAINT

"High cost of devices and treatment"

The Continuous Passive Motion Devices Market Dynamics highlight high costs of devices and associated treatment as a significant restraint. Device procurement prices and rental fees remain a barrier, especially for patients without full insurance coverage. While precise figures on cost burden vary, industry sources note that high-cost constraints are a key hindrance especially in low- and middle-income geographies where uptake is low. The Middle East & Africa region represents only 5% of global usage, partly due to limited reimbursement and cost sensitivity. High education or training fees further restrict widespread adoption. This financial friction significantly tempers expansion opportunities in the Continuous Passive Motion Devices Market Restraints.

OPPORTUNITY

"Technological advancements and home-based therapy"

The Continuous Passive Motion Devices Market Dynamics underscore opportunities in technological advancements and home-based therapy. Smart CPM devices accounted for over 8% of new product launches in Asia-Pacific in 2023, signaling innovation in sensors, connectivity, and user interfaces. Portable units hold 57% of installations, enabling therapy beyond clinical settings. The rise in remote patient monitoring and integration with mobile apps and cloud systems offers business expansion avenues. Increasing private sector investment surging by about 30% boosts R&D into digital CPM designs. Expansion into underserved markets like the Middle East & Africa (currently 5% usage) provides scope for market growth, particularly with improved cost models. This opens strategic opportunity spaces for device makers and healthcare providers under the Continuous Passive Motion Devices Market Opportunities theme.

CHALLENGE

"Variable insurance coverage and limited reimbursement"

Within Continuous Passive Motion Devices Market Dynamics, one notable challenge is variable insurance coverage. While many U.S. insurance policies cover CPM for procedures like total knee replacement, coverage for other joints or home-based use may be limited or require prior authorization. This inconsistency restricts adoption rates outside major procedures. Europe and North America account for 24.7% and 47.3% of the market share, respectively, supported by more favorable reimbursement frameworks. But in Asia-Pacific and Middle East & Africa, limited insurance mechanisms hinder uptake. This fragmentation in payer support complicates market penetration and dampens adoption beyond well-established clinical contexts an ongoing Continuous Passive Motion Devices Market Challenge.

Continuous Passive Motion Devices Market Segmentation

The Continuous Passive Motion Devices Market Segmentation Analysis splits by type and application. By type: Children below age 13 represent about 10% of users; Adults constitute 57%; Geriatric users account for 30%. By application: Knee joint devices lead with 41.3% share of installations, followed by hip and shoulder, while ankle and others occupy smaller portions. Portable design dominates overall installations at 57%, with fixed units serving the rest. This segmentation offers targeted insight into Continuous Passive Motion Devices Market Segmentation Analysis, highlighting priority user demographics and application areas.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Children Below Age 13 (10%): Pediatric CPM adoption occupies roughly 10% of total usage. Pediatric-specific devices are designed for gentle, controlled motion suited to growth considerations. Increasing awareness among clinicians and caregivers is expanding interest in pediatric CPM after procedures like ACL reconstruction or fracture repair.

The children’s segment is estimated at USD 32.08 million in 2025, representing about 5.0% of the global CPM market, with an estimated CAGR of 2.50% through 2034 (conservative estimate).

Top 5 major dominant countries in the Children Below Age 13 segment

• United States: Estimated children’s CPM market USD 10.2M, roughly 1.6% of global CPM value, estimated CAGR 2.6%, driven by pediatric post‑op protocols and home‑therapy adoption.
• Germany: Estimated children’s CPM market USD 3.2M, about 0.5% of global CPM value, estimated CAGR 2.2%, supported by pediatric orthopedic centers and hospital adoption.
• United Kingdom: Estimated children’s CPM market USD 2.4M, 0.4% global share, estimated CAGR 2.0%, with modest hospital- and clinic-based use.
• China: Estimated children’s CPM market USD 7.0M, 1.1% of global CPM, estimated CAGR 3.0%, reflecting faster clinical adoption and rising surgical volumes.
• Japan: Estimated children’s CPM market USD 2.3M, 0.36% global share, estimated CAGR 2.4%, based on hospital rehabilitation protocols and device availability.

Adult (57%): Adults comprise 57% of user base, dominating market share. This group includes working-age patients undergoing joint surgeries or trauma rehabilitation. Adult-focused devices support diverse use cases with adjustable motion ranges and ease-of-use features.

The adult segment is estimated at USD 449.05 million in 2025, representing roughly 70.0% of the global CPM market, with an estimated CAGR of 3.70% through 2034 (reflecting current market-average growth).

Top 5 major dominant countries in the Adult segment

• United States: Adult CPM market estimated USD 134.7M, 21.0% of global CPM value, estimated CAGR 3.8%, driven by high joint‑replacement volumes and hospital/home rehab adoption.
• Germany: Adult CPM market estimated USD 26.9M, 4.2% of global CPM, estimated CAGR 3.4%, backed by established orthopedic surgery rates and strong hospital procurement.
• United Kingdom: Adult CPM market estimated USD 22.5M, 3.5% of global CPM, estimated CAGR 3.2%, supported by NHS post‑operative rehab pathways and ambulatory clinics.
• China: Adult CPM market estimated USD 44.9M, 7.0% of global CPM, estimated CAGR 4.1%, reflecting rising joint surgeries and expanding home‑care device adoption.
• Japan: Adult CPM market estimated USD 18.0M, 2.8% of global CPM, estimated CAGR 3.0%, with hospital-centred rehab and steady replacement surgery volumes.

Geriatric (30%): Geriatric users account for around 30%. With rising prevalence of osteoarthritis and hip or knee replacements in aging populations, devices serving this group focus on safety, padding comfort, and minimal operational complexity to accommodate mobility limitations.

The geriatric segment is estimated at USD 128.30 million in 2025, representing approximately 20.0% of the global CPM market, with a higher estimated CAGR of 4.25% through 2034 (reported as the faster‑growing age cohort in recent reports).

Top 5 major dominant countries in the Geriatric segment

• United States: Geriatric CPM market estimated USD 38.5M, 6.0% of global CPM, estimated CAGR 4.4%, due to large elderly population and post‑op rehab programs.
• Germany: Geriatric CPM market estimated USD 7.7M, 1.2% global share, estimated CAGR 4.0%, supported by strong geriatric care infrastructure and orthopedic surgery rates.
• United Kingdom: Geriatric CPM market estimated USD 6.4M, 1.0% global share, estimated CAGR 3.8%, driven by aging population and post‑surgical rehab practices.
• China: Geriatric CPM market estimated USD 12.8M, 2.0% of global CPM, estimated CAGR 4.8%, reflecting the rapidly aging population and rising surgical throughput.
• Japan: Geriatric CPM market estimated USD 5.1M, 0.8% global share, estimated CAGR 4.1%, consistent with a large elderly patient base and post‑op rehabilitation demand.

BY APPLICATION

Hip Joint: Hip joint CPM devices form a significant, though secondary, application category. Common post-arthroplasty usage in adults and geriatrics. These devices help reduce postoperative stiffness and support controlled recovery.

Hip‑joint CPM devices are estimated at USD 96–115 million in 2025 (approximate range), representing 15%–18% of the 2025 global market, with an estimated CAGR around 3.6% due to hip arthroplasty rehabilitation demand.

Top 5 major dominant countries in the Hip Joint application

• United States: Hip CPM USD 30–35M, 4.7%–5.5% global share, estimated CAGR 3.7%, primarily hospital-led post‑arthroplasty rehab.
• Germany: Hip CPM USD 9–10M, 1.4%–1.6% share, estimated CAGR 3.3%, reflecting strong arthroplasty volumes.
• United Kingdom: Hip CPM USD 7–8M, 1.1% share, estimated CAGR 3.2%, supported by public hospital procedures.
• China: Hip CPM USD 14–18M, 2.2%–2.8% share, estimated CAGR 4.0%, with rapidly growing hip replacement numbers.
• Japan: Hip CPM USD 6–7M, 0.9%–1.1% share, estimated CAGR 3.0%, due to established surgical practice and rehab pathways.

Knee Joint (41.3%): Knee CPM devices lead installation share at about 41.3% globally. They are widely used after knee arthroplasty or ligament reconstructions to enhance mobility and synovial fluid circulation, particularly in North America and Europe.

Knee‑joint CPM devices are the largest application, estimated at USD 257–290 million in 2025 (40%–45% of global market), with an estimated CAGR 3.9% because knee arthroplasty and ligament repair are major drivers.

Top 5 major dominant countries in the Knee Joint application

• United States: Knee CPM USD 86–97M, 13%–15% of global CPM, estimated CAGR 4.0%, reflecting highest knee replacement volumes and clinical adoption.
• Germany: Knee CPM USD 25–29M, 3.9%–4.5% share, estimated CAGR 3.6%, driven by orthopedic procedure rates.
• United Kingdom: Knee CPM USD 20–23M, 3.1%–3.6% share, estimated CAGR 3.4%, used widely in post‑op pathways.
• China: Knee CPM USD 36–45M, 5.5%–7.0% share, estimated CAGR 4.3%, as knee arthroplasty expands rapidly.
• Japan: Knee CPM USD 12–14M, 1.9%–2.2% share, estimated CAGR 3.1%, supported by hospital rehabilitative practice.

Shoulder Joint: Shoulder CPM devices gain applicability in rotator cuff or shoulder replacement rehabilitation. They provide passive motion to maintain joint range of motion and prevent fibrous scar development post-surgery.

Shoulder CPM devices are estimated at USD 64–80 million in 2025 (10%–12% share), estimated CAGR 3.5%, due to moderate volumes of rotator‑cuff repairs and shoulder arthroplasties.

Top 5 major dominant countries in the Shoulder Joint application

• United States: Shoulder CPM USD 20–24M, 3.1%–3.7% global share, estimated CAGR 3.6%, used after arthroscopic and open repairs.
• Germany: Shoulder CPM USD 6–7M, estimated CAGR 3.3%, reflecting specialty sports‑medicine and shoulder surgery centers.
• United Kingdom: Shoulder CPM USD 5–6M, estimated CAGR 3.2%, used post‑repair in hospital settings.
• China: Shoulder CPM USD 8–10M, estimated CAGR 4.0%, growing with surgical adoption.
• Japan: Shoulder CPM USD 4–5M, estimated CAGR 3.0%, small but steady application segment.

Ankle Joint: Ankle CPM usage is growing, particularly following arthroscopy or ligament repair. Though representing a smaller portion than knee or hip segments, ankle devices address critical mobility restoration in lower limb rehab.

Ankle CPM devices are estimated at USD 32–48 million in 2025 (5%–7% share), estimated CAGR 3.3%, used after fracture fixation and ligament repairs.

Top 5 major dominant countries in the Ankle Joint application

• United States: Ankle CPM USD 10–15M, estimated CAGR 3.4%, substantial share due to high surgical throughput.
• Germany: Ankle CPM USD 3–5M, estimated CAGR 3.1%, reflects specialized orthopedic centers.
• United Kingdom: Ankle CPM USD 2–4M, estimated CAGR 3.0%, used selectively in hospitals.
• China: Ankle CPM USD 6–8M, estimated CAGR 3.8%, increasing with sports‑injury procedures.
• Japan: Ankle CPM USD 2–3M, estimated CAGR 3.0%, smaller niche market but stable.

Temporal Mandibular Joint: This niche application includes CPM devices designed for TMJ conditions or surgeries. These specialized units support incremental motion to prevent stiffness post-joint intervention.

TMJ CPM devices are a niche application, estimated USD 6–10 million in 2025 (below 2% share), estimated CAGR 2.5%, used in specialized cranio‑maxillofacial rehab.

Top 5 major dominant countries in the TMJ application

• United States: TMJ CPM USD 2–4M, estimated CAGR 2.6%, niche adoption in maxillofacial surgery centers.
• Germany: TMJ CPM USD 0.8–1.2M, estimated CAGR 2.4%, used in specialty clinics.
• United Kingdom: TMJ CPM USD 0.6–1.0M, estimated CAGR 2.2%, limited hospital adoption.
• China: TMJ CPM USD 1.2–1.8M, estimated CAGR 3.0%, modest growth as specialty care expands.
• Japan: TMJ CPM USD 0.4–0.8M, estimated CAGR 2.3%, very niche but steady.

Continuous Passive Motion Devices Market Regional Outlook

Regional performance varies significantly. North America leads with 47.3% global market share, bolstered by high institutional adoption, joint surgery volumes, and portable CPM usage. Europe follows at 24.7%, supported by hospitals and ambulatory centers using 60% of devices. Asia-Pacific holds 17.6%, with increasing home-care (nearly 20%) and smart device penetration (8% of new launches). Middle East & Africa accounts for 5%, constrained by infrastructure and cost, though trauma rehabilitation demand exists. Across regions, portable devices dominate, with adult users forming the primary demographic segment.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

In North America, the Continuous Passive Motion Devices Market exhibits commanding dominance with 47.3% of global share. Hospital and rehabilitation center settings account for roughly 60% of device deployments, reflecting institutional reliance. Knee joint CPM units represent 41.3% of installations, largely used following high volumes of joint replacements annual procedures numbering more than 427,000 between 2012 and 2015, trending toward 4 million by 2030. Portable CPM models, at 57%, enable post-discharge rehabilitation, a crucial need given patient preference and clinical protocols in this region. Adult users form 57%, geriatrics 30%, children 10%, creating balanced demographic coverage. Regulatory approvals by the U.S. FDA in 2023 facilitated smart portable CPM launches comprising over 8% of new entries. These factors reinforce North America’s leadership as detailed in Continuous Passive Motion Devices Market Report.

North America is the largest regional market, estimated at roughly USD 303–310 million in 2025 (≈47% of the global CPM market), with an estimated CAGR around 3.6%–3.9%, led by the U.S. and strong hospital/home rehabilitation adoption.

North America Major dominant countries

• United States: Market estimated USD 275–285M in 2025, representing 43%–44% of the global market, estimated CAGR 3.8%, driven by high procedure volumes and reimbursement pathways.
• Canada: Market estimated USD 12–16M, 1.9%–2.5% global share, estimated CAGR 3.2%, hospital- and clinic-focused adoption.
• Mexico: Market estimated USD 6–9M, estimated CAGR 3.5%, smaller but growing with private hospitals and rehab clinics.
• Puerto Rico: Market estimated USD 1–2M, estimated CAGR 3.1%, niche volume relative to continental markets.
• Other North America (Caribbean): Combined smaller markets USD 1–2M, estimated CAGR 3.0%, limited but steady.

EUROPE

Europe holds about 24.7% of the global Continuous Passive Motion Devices Market. Within the region, portable CPM units account for over 50% of installations, enabling both hospital and home-based care. Hospitals and ambulatory surgical centers together hold nearly 60% of the installed base. Knee joint devices lead at approximately 40%, with hip and shoulder segments comprising the rest. Adult and geriatric users represent nearly 85% combined, reflecting aging demographics and post-surgical rehabilitation demand. European regulatory frameworks ensure device safety and encourage adoption, supported by insurance mechanisms in major countries. Smart and portable models have seen timely approvals in 2023, offering improved remote monitoring and user interfaces. These dynamics underpin Europe’s stable and innovation-driven position in the Continuous Passive Motion Devices Market Analysis.

Europe is the second‑largest region with an estimated USD 158–170 million in 2025 (24%–26% share), estimated CAGR 3.2%–3.6%, supported by high surgical rates in Western Europe.

Europe Major dominant countries

• Germany: Market estimated USD 40–45M, 6.5%–7.0% global share, estimated CAGR 3.4%, major orthopedic device purchaser.
• United Kingdom: Market estimated USD 33–36M, 5%–5.6% share, estimated CAGR 3.2%, with NHS-led adoption.
• France: Market estimated USD 18–22M, estimated CAGR 3.1%, driven by hospital rehab and private clinics.
• Italy: Market estimated USD 12–15M, estimated CAGR 3.0%, stable orthopedic device demand.
• Spain: Market estimated USD 10–12M, estimated CAGR 3.0%, steady hospital adoption.

ASIA-PACIFIC

The Asia-Pacific region accounts for 17.6% of the global Continuous Passive Motion Devices Market. Portable device use exceeds 50%, with home-care applications rising to nearly 20% of usage. Lower limb devices, especially for knees, represent about 35%, and total lower limb share is roughly 55%. Demographically, adults account for 57%, geriatrics 30%, and children 10% of device users. Growth is driven by increasing joint reconstruction surgeries, aging populations in countries such as India, China, and Japan, and expanding healthcare access. Smart device innovation contributed to over 8% of new product launches in 2023, enhancing adoption through better usability and remote features. While reimbursement is limited in some markets, increasing healthcare investment and development of local distribution channels are expanding CPM acceptance. These factors explain why Asia-Pacific remains a fast-growing regional segment in the Continuous Passive Motion Devices Market Outlook.

Asia (APAC) is estimated at USD 112–125 million in 2025 (17%–19% share), with higher-growth potential (estimated CAGR 4.0%–4.5%), led by China, Japan, and expanding adoption in South Korea and Southeast Asia.

Asia Major dominant countries

• China: Market estimated USD 45–55M, 7%–8% global share, estimated CAGR 4.0%–4.8%, fastest regional growth driven by surgical volume expansion.
• Japan: Market estimated USD 20–23M, 3%–3.5% share, estimated CAGR 3.1%–3.5%, established hospital adoption.
• South Korea: Market estimated USD 8–10M, estimated CAGR 3.8%, strong orthopedic practice and device uptake.
• India: Market estimated USD 6–9M, estimated CAGR 4.5%, growing from low penetration and rising surgical volumes.
• Australia: Market estimated USD 5–6M, steady estimated CAGR 3.2%, hospital and home‑care uptake.

MIDDLE EAST & AFRICA

Middle East & Africa constitutes about 5% of global usage within the Continuous Passive Motion Devices Market. Device adoption is primarily driven by trauma rehabilitation needs global falls exceeding 37.3 million incidents contribute to demand for post-trauma joint motion support. Knee CPM devices account for around 40% of regional installations, with hip and shoulder devices covering the rest. Portable CPM models compose over 45% of units, while fixed units remain significant in clinical settings. Adult users form 60%, geriatrics 30%, and children 10%. However, uptake is restrained by limited healthcare infrastructure, inadequate reimbursement frameworks, and high unit costs. Specialized rehabilitation centers and hospitals install most equipment. Strategic outreach by manufacturers, local partnerships, and targeted education initiatives may enhance future adoption in this underrepresented region of the Continuous Passive Motion Devices Market Research Report.

Middle East & Africa combined are estimated at USD 25–35 million in 2025 (4%–6% share), estimated CAGR 3.0%–3.5%, with GCC countries showing stronger public/private hospital demand.

Middle East & Africa Major dominant countries

• Saudi Arabia: Market estimated USD 6–8M, estimated CAGR 3.6%, sizable public hospital procurement and rehab programs.
• United Arab Emirates: Market estimated USD 4–6M, estimated CAGR 3.4%, private hospital adoption and medical tourism support.
• South Africa: Market estimated USD 3–4M, estimated CAGR 3.0%, leading African market with private hospitals.
• Israel: Market estimated USD 2–3M, estimated CAGR 3.2%, specialty rehabilitation centers.
• Egypt: Market estimated USD 2–3M, estimated CAGR 3.0%, emerging hospital demand.

List of Top Continuous Passive Motion Devices Companies

• Chattanooga
• Surgi-Care
• BTL
• Rimec
• Furniss
• Bio-Med
• OPED
• Medival
• Chinesport

Top Two Companies with Highest Market Share

• Chattanooga: Chattanooga holds one of the largest global market shares in the Continuous Passive Motion Devices Market. It dominates due to its advanced rehabilitation equipment portfolio and distribution in over 80 countries worldwide. The company’s CPM devices are widely used in hospitals and rehabilitation centers, contributing to its market leadership. With portable and hospital-grade models, Chattanooga addresses both institutional (44.2% share) and home-care segments. Strong partnerships with clinics and investment in R&D position it as a leader in the Continuous Passive Motion Devices Market Analysis.
• Furniss: The Furniss Corporation ranks as another top market shareholder with extensive adoption in the U.S. and Europe. Its CPM devices are known for user-friendly designs and durable performance. The company supports hospitals, clinics, and rental markets, with rapid product service turnaround often within 72 hours. Furniss accounts for a major share of portable CPM deployments (57% globally) and specializes in knee joint units, which hold 41.3% of the global market segment. The company’s emphasis on ergonomic designs and patient compliance reinforces its competitive strength in the Continuous Passive Motion Devices Industry Report.

Investment Analysis and Opportunities

In the Continuous Passive Motion Devices Market Investment Analysis and Opportunities, several quantitative indicators emerge. Private sector investment has surged by approximately 30%, fueling innovation and product enhancements. Market share for smart portable CPM device launches in Asia-Pacific exceeded 8% in 2023, signaling R&D-driven expansion. In North America, institutions perform over 427,000 joint replacements annually, projected to approach 4 million by 2030, offering sustained demand. Portable devices make up 57% of installations globally, emphasizing market preference. Regions like Middle East & Africa currently hold 5% share, presenting opportunities for growth through infrastructure development and targeted investment. The smart device segment’s share of new launches underscores scope for telehealth integration. Firms can capitalize on adult user base (57%), while pediatric (10%) and geriatric (30%) segments offer niche penetration strategies. Overall, rising volume of orthopedic procedures, technological proliferation, and regional under-penetration furnish compelling investment prospects within this Continuous Passive Motion Devices Industry Report.

New Product Development

The Continuous Passive Motion Devices Market has witnessed significant innovation with over 25+ new product variants launched between 2023 and 2025, focusing on portability, automation, and digital integration. Modern Continuous Passive Motion Devices Market products now include smart sensors with motion tracking accuracy of up to 95%, enabling real-time monitoring of joint movement angles ranging between 0° to 120°. Manufacturers are integrating Bluetooth-enabled systems in nearly 40% of newly launched devices, allowing remote control via mobile applications. Battery-operated portable CPM devices now account for approximately 35% of new product launches, with battery life extending up to 8–12 hours per charge, improving usability in home healthcare settings. Advanced knee CPM machines now support weight capacities of up to 150 kg and offer adjustable speed settings between 1 to 3 cycles per minute. Continuous Passive Motion Devices Market trends show that about 30% of innovations are focused on compact designs, reducing device weight by 20% compared to earlier models. Continuous Passive Motion Devices Market Analysis also indicates the introduction of AI-assisted therapy modes in 10% of premium devices, optimizing recovery cycles based on patient data inputs. These Continuous Passive Motion Devices Market innovations are aligned with rising demand in orthopedic rehabilitation, where over 60% of post-surgical patients require assisted motion therapy within the first 72 hours.

Five Recent Developments (2023-2025)

• In 2023, a leading manufacturer introduced a knee CPM device with a motion range of 0° to 135°, improving flexibility by nearly 12% compared to earlier models used in the Continuous Passive Motion Devices Market.
• In early 2024, a company launched a fully portable CPM unit weighing under 9 kg, reducing device weight by approximately 25%, targeting home-based rehabilitation in the Continuous Passive Motion Devices Industry.
• In mid-2024, integration of IoT technology in CPM devices increased device connectivity by 45%, enabling remote therapy monitoring across more than 20 clinical settings simultaneously.
• In 2025, a new elbow CPM device was introduced with adjustable torque settings ranging from 5 Nm to 20 Nm, enhancing precision in upper limb rehabilitation within the Continuous Passive Motion Devices Market.
• Another 2025 development included the introduction of multi-joint CPM systems supporting knee, hip, and shoulder therapy in a single device, increasing therapy efficiency by 30% and reducing equipment dependency by 2 devices per clinic on average.

Report Coverage of Continuous Passive Motion Devices Market

The Continuous Passive Motion Devices Market Report provides comprehensive coverage across more than 15 countries, analyzing over 50+ manufacturers and 100+ product variants within the Continuous Passive Motion Devices Industry. The Continuous Passive Motion Devices Market Analysis includes segmentation by product type, such as knee CPM devices accounting for approximately 55% share, shoulder CPM devices contributing nearly 20%, and other joint devices covering around 25%. The Continuous Passive Motion Devices Market Research Report evaluates usage across hospitals, rehabilitation centers, and home care settings, where hospital usage accounts for nearly 60% of total device deployment. The report examines device specifications including motion range (0°–135°), patient weight capacity (up to 150 kg), and therapy duration cycles ranging between 30 to 120 minutes per session. Continuous Passive Motion Devices Market Insights also include data on adoption rates, where nearly 70% of orthopedic surgeries involving knee replacement utilize CPM therapy within the first 48–72 hours. The Continuous Passive Motion Devices Market Outlook highlights supply chain distribution involving over 200 distributors globally and emphasizes increasing demand from aging populations, where individuals aged 60+ represent more than 65% of total end users. Continuous Passive Motion Devices Market Forecast and Continuous Passive Motion Devices Market Opportunities are further detailed through technological adoption rates, with smart devices accounting for nearly 40% of current installations.

Continuous Passive Motion Devices Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 665.3 Million in 2026
Market Size Value By	USD 923.59 Million by 2035
Growth Rate	CAGR of 3.71% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Hip Joint Knee Joint Shoulder Joint Ankle Joint Temporal Mandibular Joint By Application : Children Below Age 13 Adult Geriatric
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample